SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jeffrey J. Leow, Anna Orsola, Steven L. Chang, Joaquim Bellmunt, A contemporary review of management and prognostic factors of upper tract urothelial carcinoma, Cancer Treatment Reviews, 2015, 41, 4, 310

    CrossRef

  2. 2
    Laura-Maria Krabbe, Aditya Bagrodia, Ahmed Q. Haddad, Payal Kapur, Dina Khalil, Linda S. Hynan, Christopher G. Wood, Jose A. Karam, Alon Z. Weizer, Jay D. Raman, Mesut Remzi, Nathalie Rioux-Leclercq, Andrea Haitel, Marco Roscigno, Christian Bolenz, Karim Bensalah, Arthur I. Sagalowsky, Shahrokh F. Shariat, Yair Lotan, Vitaly Margulis, Multi-institutional Validation of the Predictive Value of Ki-67 in Patients with High Grade Urothelial Carcinoma of the Upper Urinary Tract, The Journal of Urology, 2015, 193, 5, 1486

    CrossRef

  3. 3
    Ramy F. Youssef, Laura-Maria Krabbe, Shahrokh F. Shariat, Yair Lotan, Arthur I. Sagalowsky, Jay Raman, Christopher G. Wood, Alon Weizer, Marco Roscigno, Francesco Montorsi, Christian Bolenz, Mesut Remzi, Karim Bensalah, Wassim Kassouf, Vitaly Margulis, TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma, World Journal of Urology, 2015,

    CrossRef

  4. 4
    P. Colin, J. Irani, S.J. Drouin, S.F. Shariat, M. Rouprêt, Facteurs pronostiques des tumeurs de la voie excrétrice supérieure et impact sur la survie : une revue systématique pour le rapport annuel de l’Association française d’urologie, Progrès en Urologie, 2014, 24, 15, 1000

    CrossRef

  5. 5
    Evanguelos Xylinas, Luis Kluth, Niccolo Passoni, Quoc-Dien Trinh, Malte Rieken, Richard K. Lee, Harun Fajkovic, Giacomo Novara, Vitaly Margulis, Jay D. Raman, Yair Lotan, Morgan Rouprêt, Atiqullah Aziz, Hans-Martin Fritsche, Alon Weizer, Juan I. Martinez-Salamanca, Kazumasa Matsumoto, Christian Seitz, Mesut Remzi, Thomas Walton, Pierre I. Karakiewicz, Francesco Montorsi, Marc Zerbib, Douglas S. Scherr, Shahrokh F. Shariat, Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool, European Urology, 2014, 65, 3, 650

    CrossRef

  6. 6
    Chenchen Feng, Lujia Wang, Guanxiong Ding, Qiang Ding, Zhongwen Zhou, Haowen Jiang, Zhong Wu, Predictive Value of Clinicopathological Markers for the Metachronous Bladder Cancer and Prognosis of Upper Tract Urothelial Carcinoma, Scientific Reports, 2014, 4,

    CrossRef

  7. 7
    Takeshi Hashimoto, Jun Nakashima, Rie Inoue, Tatsuo Gondo, Yoshio Ohno, Masaaki Tachibana, Prognostic implication of infiltrative growth pattern and establishment of novel risk stratification model for survival in patients with upper urinary tract urothelial carcinoma, International Journal of Clinical Oncology, 2014, 19, 2, 373

    CrossRef

  8. 8
    Laura-Maria Krabbe, Yair Lotan, Aditya Bagrodia, Bishoy A. Gayed, Oussama M. Darwish, Ramy F. Youssef, Christian Bolenz, Arthur I. Sagalowsky, Ganesh V. Raj, Shahrokh F. Shariat, Payal Kapur, Vitaly Margulis, Prospective Comparison of Molecular Signatures in Urothelial Cancer of the Bladder and the Upper Urinary Tract—Is There Evidence for Discordant Biology?, The Journal of Urology, 2014, 191, 4, 926

    CrossRef

  9. 9
    Yu-Kuan Lin, Matthew Kaag, Jay D Raman, Rationale and timing of perioperative chemotherapy for upper-tract urothelial carcinoma, Expert Review of Anticancer Therapy, 2014, 14, 5, 543

    CrossRef

  10. You have free access to this content10
    Orietta Dalpiaz, Georg C. Ehrlich, Sebastian Mannweiler, Jessica M.Martín Hernández, Armin Gerger, Tatjana Stojakovic, Karl Pummer, Richard Zigeuner, Martin Pichler, Georg C. Hutterer, Validation of pretreatment neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma, BJU International, 2014, 114, 3
  11. 11
    O Dalpiaz, M Pichler, S Mannweiler, J M Martín Hernández, T Stojakovic, K Pummer, R Zigeuner, G C Hutterer, Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma, British Journal of Cancer, 2014, 110, 10, 2531

    CrossRef

  12. 12
    Sarah J. Drouin, David R. Yates, Vincent Hupertan, Olivier Cussenot, Morgan Rouprêt, A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting, World Journal of Urology, 2013, 31, 1, 109

    CrossRef

  13. 13
    J H Ku, K C Moon, J H Jung, S H Jeong, C Kwak, H H Kim, External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma, British Journal of Cancer, 2013, 109, 5, 1130

    CrossRef

  14. 14
    Evanguelos Xylinas, Michael Rink, Vitaly Margulis, Talia Faison, Evi Comploj, Giacomo Novara, Jay D. Raman, Yair Lotan, Bertrand Guillonneau, Alon Weizer, Armin Pycha, Douglas S. Scherr, Christian Seitz, Maxine Sun, Quoc-Dien Trinh, Pierre I. Karakiewicz, Francesco Montorsi, Marc Zerbib, Mithat Gönen, Shahrokh F. Shariat, Prediction of True Nodal Status in Patients with Pathological Lymph Node Negative Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy, The Journal of Urology, 2013, 189, 2, 468

    CrossRef

  15. 15
    Evanguelos Xylinas, Luis Kluth, Sibani Mangal, Morgan Roupret, Pierre I. Karakiewicz, Shahrokh F. Shariat, Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma, World Journal of Urology, 2013, 31, 1, 31

    CrossRef

  16. You have free access to this content16
    Kazutoshi Fujita, Go Tanigawa, Ryoichi Imamura, Masahiro Nakagawa, Takuji Hayashi, Nozomu Kishimoto, Masahiro Hosomi, Seiji Yamaguchi, Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy, International Journal of Urology, 2013, 20, 6
  17. 17
    H. Kitamura, M. Igarashi, T. Tanaka, T. Shindo, N. Masumori, M. Tamakawa, Y. Kawaai, T. Tsukamoto, A Role for Preoperative Systemic Chemotherapy in Node-positive Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy, Japanese Journal of Clinical Oncology, 2012, 42, 12, 1192

    CrossRef

  18. 18
    D R Yates, V Hupertan, P Colin, A Ouzzane, A Descazeaud, J A Long, G Pignot, S Crouzet, F Rozet, Y Neuzillet, M Soulie, T Bodin, A Valeri, O Cussenot, M Rouprêt, Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram, British Journal of Cancer, 2012, 106, 6, 1083

    CrossRef

  19. 19
    Evanguelos Xylinas, Morgan Rouprêt, Luis Kluth, Douglas S. Scherr, Shahrokh F. Shariat, Collaborative Research Networks as a Platform for Virtual Multidisciplinary, International Approach to Managing Difficult Clinical Cases: An Example from the Upper Tract Urothelial Carcinoma Collaboration, European Urology, 2012, 62, 5, 943

    CrossRef

  20. 20
    Pierre Colin, Adil Ouzzane, David R. Yates, Audenet François, Géraldine Pignot, Alexis Arvin-Berod, Olivier Merigot de Treigny, Guy Laurent, Antoine Valeri, Irani Jacques, Fabien Saint, Solène Gardic, Pascal Gres, François Rozet, Yann Neuzillet, Alain Ruffion, Morgan Rouprêt, Influence of Positive Surgical Margin Status After Radical Nephroureterectomy on Upper Urinary Tract Urothelial Carcinoma Survival, Annals of Surgical Oncology, 2012, 19, 11, 3613

    CrossRef

  21. 21
    M. Rouprêt, L’existence d’emboles vasculaires tumoraux doit être mentionnée sur le compte rendu anatomopathologique après exérèse d’une tumeur de la voie excrétrice urinaire supérieure, Progrès en Urologie, 2012, 22, 6, 363

    CrossRef

  22. 22
    Eugene K. Cha, Shahrokh F. Shariat, Matthias Kormaksson, Giacomo Novara, Thomas F. Chromecki, Douglas S. Scherr, Yair Lotan, Jay D. Raman, Wassim Kassouf, Richard Zigeuner, Mesut Remzi, Karim Bensalah, Alon Weizer, Eiji Kikuchi, Christian Bolenz, Marco Roscigno, Theresa M. Koppie, Casey K. Ng, Hans-Martin Fritsche, Kazumasa Matsumoto, Thomas J. Walton, Behfar Ehdaie, Stefan Tritschler, Harun Fajkovic, Juan I. Martínez-Salamanca, Armin Pycha, Cord Langner, Vincenzo Ficarra, Jean-Jacques Patard, Francesco Montorsi, Christopher G. Wood, Pierre I. Karakiewicz, Vitaly Margulis, Predicting Clinical Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma, European Urology, 2012, 61, 4, 818

    CrossRef

  23. 23
    Giovanni Lughezzani, Maximilian Burger, Vitaly Margulis, Surena F. Matin, Giacomo Novara, Morgan Roupret, Shahrokh F. Shariat, Christopher G. Wood, Richard Zigeuner, Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature, European Urology, 2012, 62, 1, 100

    CrossRef

  24. 24
    Aditya Bagrodia, Ramy F. Youssef, Payal Kapur, Oussama M. Darwish, Chase Cannon, Michael J. Belsante, Deniz Gerecci, Arthur I. Sagalowsky, Shahrokh F. Shariat, Yair Lotan, Vitaly Margulis, Prospective Evaluation of Molecular Markers for the Staging and Prognosis of Upper Tract Urothelial Carcinoma, European Urology, 2012, 62, 1, e27

    CrossRef

  25. You have free access to this content25
    Alexis Arvin Berod, Pierre Colin, David R. Yates, Adil Ouzzane, Marie Audouin, Emilie Adam, Frédéric Arroua, Charles Marchand, Pierre Bigot, Michel Soulié, Mathieu Roumiguié, Thomas Polguer, Solène Gardic, Pascal Grès, Emmanuel Ravier, Yann Neuzillet, Francky Delage, Thomas Bodin, Géraldine Pignot, Morgan Rouprêt, The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study, BJU International, 2012, 110, 11c
  26. 26
    Mototsugu Muramaki, Hideaki Miyake, Tomoaki Terakawa, Yuji Kusuda, Masato Fujisawa, Expression Profile of E-cadherin and N-cadherin in Urothelial Carcinoma of the Upper Urinary Tract is Associated with Disease Recurrence in Patients Undergoing Nephroureterectomy, Urology, 2011, 78, 6, 1443.e7

    CrossRef

  27. 27
    Grégory Verhoest, Shahrokh F. Shariat, Thomas F. Chromecki, Jay D. Raman, Vitaly Margulis, Giacomo Novara, Christian Seitz, Mesut Remzi, Morgan Rouprêt, Douglas S. Scherr, Karim Bensalah, Predictive factors of recurrence and survival of upper tract urothelial carcinomas, World Journal of Urology, 2011, 29, 4, 495

    CrossRef

  28. 28
    Maxine Sun, Al’a Abdo, Firas Abdollah, Jan Schmitges, Rodolphe Thuret, Claudio Jeldres, Shahrokh F Shariat, Paul Perrotte, Pierre I Karakiewicz, Management of upper urinary tract urothelial carcinoma, Expert Review of Anticancer Therapy, 2010, 10, 12, 1955

    CrossRef

  29. 29
    Rebecca Drake, Urothelial carcinoma: A novel nomogram for post-nephroureterectomy prognosis, Nature Reviews Urology, 2010, 7, 10, 534

    CrossRef